Fexofenadine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fexofenadine Hydrochloride
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Fexofenadine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

78 API Suppliers, 24 USDMF, 12 CEP/COS, 15 JDMF, 14 EU WC, 10 KDMF, 25 NDC API, 47 Listed Suppliers, $ API Reference Price

78 API Suppliers
24 USDMF
12 CEP/COS
15 JDMF
14 EU WC
10 KDMF
25 NDC API
47 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

26 Intermediates Suppliers

26 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

288 FDF Dossiers, 96 FDA Orange Book, 76 Europe, 4 Canada, 5 Australia, 30 South Africa, 77 Listed Dossiers

288 FDF Dossiers
96 FDA Orange Book
76 Europe
4 Canada
5 Australia
30 South Africa
77 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 30MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, TABLET;ORAL - 180MG, TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, SUSPENSION;ORAL - 30MG/5ML

SUSPENSION;ORAL - 30MG/5ML
TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG
TABLET;ORAL - 180MG
TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 60MG
TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG
TABLET, ORALLY DISINTEGRATING;ORAL - 30MG
SUSPENSION;ORAL - 30MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 11 DKSH, 3 Jai Radhe Sales, 2 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 36 BASF, 1 Bioplus Life Sciences, 1 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

114 Fillers, Diluents & Binders, 59 Coating Systems & Additives, 55 Direct Compression, 44 Thickeners and Stabilizers, 44 Disintegrants & Superdisintegrants, 36 Controlled & Modified Release, 36 Granulation, 32 Solubilizers, 31 Taste Masking, 29 Lubricants & Glidants, 28 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 22 Topical, 22 Co-Processed Excipients, 20 Parenteral, 9 Empty Capsules, 9 API Stability Enhancers, 8 Emulsifying Agents, 7 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

114 Fillers, Diluents & Binders
59 Coating Systems & Additives
55 Direct Compression
44 Thickeners and Stabilizers
44 Disintegrants & Superdisintegrants
36 Controlled & Modified Release
36 Granulation
32 Solubilizers
31 Taste Masking
29 Lubricants & Glidants
28 Film Formers & Plasticizers
23 Chewable & Orodispersible Aids
22 Topical
22 Co-Processed Excipients
20 Parenteral
9 Empty Capsules
9 API Stability Enhancers
8 Emulsifying Agents
7 Rheology Modifiers
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

74 Finished Drug Prices, 9 Annual Reports

74 Finished Drug Prices
9 Annual Reports

MARKET PLACE

32 APIs, 2 FDF Dossiers

32 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 13 Health Canada Patents

2 US Patents
13 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 4 JP, 6 Others

4 EDQM
3 USP
4 JP
6 Others

ANALYTICAL

1 BioAnalytical Methods, 5 Analytical Methods

1 BioAnalytical Methods
5 Analytical Methods

$ API Ref.Price (USD/KG) : 131 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2CHATTEM SANOFI

filter Patent Number Reset all filters

2 All

01 28933097

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22030-08-02

Virupaksha Fexofenadine HCl

Product Main Page

01

CHATTEM SANOFI

FEXOFENADINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

CHATTEM SANOFI

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-08-02

FEXOFENADINE HYDROCHLORIDE

US Patent Number : 8933097

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201373

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-08-02

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

CHATTEM SANOFI

FEXOFENADINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

CHATTEM SANOFI

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-08-02

FEXOFENADINE HYDROCHLORIDE

US Patent Number : 8933097

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201373

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-08-02

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?